Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Standard BioTools
LAB
$306M
| $13.4M | ﹤0.01% |
6,949,717
+154,848
| +2% | +$303K |
|
2202
Autohome
ATHM
$2.66B
| $13.4M | ﹤0.01% |
413,932
+13,944
| +3% | +$364K |
|
2203
Anterix
ATEX
$1.8B
| $13.4M | ﹤0.01% |
355,484
-8,259
| -2% | -$318K |
|
2204
Nabors Industries
NBR
$1.3B
| $13.3M | ﹤0.01% |
206,041
+3,054
| +2% | +$236K |
|
2205
Dianthus Therapeutics
DNTH
$6.08B
| $13.3M | ﹤0.01% |
485,121
-13,799
| -3% | -$384K |
|
2206
Washington Trust Bancorp
WASH
$736M
| $13.3M | ﹤0.01% |
412,346
-794
| -0.2% | -$24.3K |
|
2207
Arbutus Biopharma
ABUS
$911M
| $13.3M | ﹤0.01% |
3,448,600
+135,442
| +4% | +$520K |
|
2208
GigaCloud Technology
GCT
$1.83B
| $13.3M | ﹤0.01% |
577,108
+274,506
| +91% | +$6.59M |
|
2209
Compañía de Minas Buenaventura
BVN
$8.75B
| $13.2M | ﹤0.01% |
964,014
+20,899
| +2% | +$303K |
|
2210
Thryv Holdings
THRY
$97.8M
| $13.2M | ﹤0.01% |
767,137
-49,074
| -6% | -$878K |
|
2211
UWM Holdings
UWMC
$475M
| $13.2M | ﹤0.01% |
1,546,818
+41,206
| +3% | +$347K |
|
2212
Sana Biotechnology
SANA
$1.02B
| $13.2M | ﹤0.01% |
3,166,480
+276,055
| +10% | +$1.45M |
|
2213
Alphatec Holdings
ATEC
$1.46B
| $13.1M | ﹤0.01% |
2,362,879
-34,906
| -1% | -$268K |
|
2214
Equity Bancshares
EQBK
$1.04B
| $13.1M | ﹤0.01% |
320,919
-163
| -0.1% | -$6.35K |
|
2215
Orthofix Medical
OFIX
$420M
| $13.1M | ﹤0.01% |
839,189
+11,559
| +1% | +$185K |
|
2216
Loar Holdings
LOAR
$6.61B
| $13.1M | ﹤0.01% |
175,575
+2,551
| +1% | +$169K |
|
2217
Garrett Motion
GTX
$5.51B
| $13.1M | ﹤0.01% |
1,599,403
-42,039
| -3% | -$354K |
|
2218
Clean Energy Fuels
CLNE
$348M
| $13.1M | ﹤0.01% |
4,203,217
+126,760
| +3% | +$359K |
|
2219
Leslie's
LESL
$10.7M
| $13.1M | ﹤0.01% |
206,735
-3,289
| -2% | -$203K |
|
2220
Oric Pharmaceuticals
ORIC
$1.38B
| $13.1M | ﹤0.01% |
1,273,513
+50,821
| +4% | +$502K |
|
2221
Applied Optoelectronics
AAOI
$11.2B
| $13M | ﹤0.01% |
909,559
+60,241
| +7% | +$625K |
|
2222
MetroCity Bankshares
MCBS
$1.02B
| $13M | ﹤0.01% |
424,739
+6,341
| +2% | +$184K |
|
|
DOO
2223
Bombardier Recreational Products
DOO
$4.73B
| $13M | ﹤0.01% |
208,186
+15,892
| +8% | +$1.05M |
|
2224
Aurinia Pharmaceuticals
AUPH
$2.06B
| $12.9M | ﹤0.01% |
1,766,370
+2,768
| +0.2% | +$17.2K |
|
2225
SI-BONE Inc
SIBN
$849M
| $12.9M | ﹤0.01% |
924,044
+30,005
| +3% | +$451K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.